v3.26.1
Share-Based Compensation (Tables)
6 Months Ended
Jun. 30, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of Share-Based Compensation Expense
The Company recognized share-based compensation in its Condensed Statements of Operations and Comprehensive Loss during the three and six months ended June 30, 2026 and 2025 as follows:
Three Months Ended
June 30,
Six Months Ended
June 30,
2026202520262025
Manufacture and supply$66 $128 $135 $228 
Research and development313 408 549 738 
Selling, general and administrative2,516 1,348 4,529 2,505 
Total share-based compensation expenses$2,895 $1,884 $5,213 $3,471 
Share-based compensation from:
Restricted stock units$1,821 $1,407 $3,476 $2,509 
Stock options1,062 468 1,725 953 
Employee stock purchase plan (ESPP)12 12 
Total share-based compensation expenses$2,895 $1,884 $5,213 $3,471 
Schedule of Restricted Stock Units Awards
The following tables summarize the Company’s awards of service-based and market conditions vesting-based restricted stock units for the six month period ended June 30, 2026:
Restricted Stock Unit Awards (RSUs) - Service-based:Number of
Units
Weighted
Average
Grant Date Fair
Value
(in thousands)
Unvested as of December 31, 20252,684 $3.24 
Granted1,418 $4.28 
Vested(1,367)$2.63 
Forfeited(26)$4.12 
Unvested as of June 30, 20262,709 $4.08 
Expected to vest as of June 30, 20262,504 $4.09 
Schedule of Stock Option Activity
Restricted Stock Unit Awards (RSUs) - Market conditions vesting-based:Number of
Units
Weighted
Average
Grant Date Fair
Value
(in thousands)
Unvested as of December 31, 20251,728 $2.55 
Granted (a)
541 2.40 
Vested(1,706)2.28 
Forfeited— — 
Unvested as of June 30, 2026563 $2.82 
Expected to vest as of June 30, 2026517 $2.82 
(a) The 2023 market conditions vesting-based restricted stock units vested at 150% in May 2026. These additional units were granted during the three months ended June 30, 2026.
Stock Option Awards:Number of
Options
Weighted Average
Exercise Price
(in thousands)
Outstanding as of December 31, 20256,558 $5.59 
Granted1,324 4.21 
Exercised(36)0.76 
Forfeited/Expired(1)3.84 
Outstanding as of June 30, 20267,845 $5.38 
Expected to vest as of June 30, 20267,696 $5.40 
Exercisable as of June 30, 20265,806 $5.83 
Schedule of Stock Option Valuation Assumptions
The Company’s estimates of the fair value of the 2025 market conditions vesting-based awards at their grant or valuation dates were based on a Monte Carlo simulation and considered various variables and the following assumptions:
Expected dividend yield0%
Expected volatility91.5%
Risk-free interest rate3.9%
Stock price at grant date
$2.65
The fair values of stock options granted were estimated using the Black-Scholes pricing model based on the following assumptions:
Six Months Ended
June 30, 2026
Expected dividend yield—%—%
Expected volatility96%98%
Expected term (years)5.56.1
Risk-free interest rate3.8%4.4%